Arkolith/Insider Trading/DNLI/Form 4

Schuth Alexander O.

COFO and SecretaryDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Nov 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$465K
Net Open-Market Flow
-$465K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2024Sell(S)12K$29.68$366K181K
Nov 7, 2024Sell(S)3K$30.72$90K178K
Nov 7, 2024Sell(S)300$31.29$9K178K
Nov 7, 2024Option exercise(M)16K$5.28$82K194K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 7, 2024Option exercise(M)16K—$053K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-24-000218) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML